Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|February 2, 2013
The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancerHiroyuki Monma, Nanae Harashima, Touko Inao, et al.
International Journal of Cancer|May 7, 2002
Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell responseToshiki Yajima, Hitoshi Nishimura, Worawidh Wajjwalku, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulationNaoya Hida, Yoshiaki Maeda, Kazuko Katagiri, et al.
Cancer Medicine|November 11, 2021
Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor-induced senescence in breast cancer cellsIrna D Kartika, Hitoshi Kotani, Yuichi Iida, et al.
Plos One|November 19, 2013
Pifithrin-μ, an inhibitor of heat-shock protein 70, can increase the antitumor effects of hyperthermia against human prostate cancer cellsKazumasa Sekihara, Nanae Harashima, Miki Tongu, et al.
The Prostate|June 4, 2004
A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patientsSatoko Matsueda, Akihisa Yao, Yuki Ishihara, et al.
Oncotarget|June 8, 2018
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicinTouko Inao, Yuichi Iida, Tamami Moritani, et al.
Oncology Reports|July 6, 2007
Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancerShigenori Homma, Yoshihiro Komohara, Mamoru Harada, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivoMiki Tongu, Nanae Harashima, Hiroyuki Monma, et al.
Oncology Reports|January 5, 2006
Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patientsYi Wang, Mamoru Harada, Hirohisa Yano, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|February 2, 2013
The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancerHiroyuki Monma, Nanae Harashima, Touko Inao, et al.
International Journal of Cancer|May 7, 2002
Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell responseToshiki Yajima, Hitoshi Nishimura, Worawidh Wajjwalku, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulationNaoya Hida, Yoshiaki Maeda, Kazuko Katagiri, et al.
Cancer Medicine|November 11, 2021
Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor-induced senescence in breast cancer cellsIrna D Kartika, Hitoshi Kotani, Yuichi Iida, et al.
Plos One|November 19, 2013
Pifithrin-μ, an inhibitor of heat-shock protein 70, can increase the antitumor effects of hyperthermia against human prostate cancer cellsKazumasa Sekihara, Nanae Harashima, Miki Tongu, et al.
The Prostate|June 4, 2004
A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patientsSatoko Matsueda, Akihisa Yao, Yuki Ishihara, et al.
Oncotarget|June 8, 2018
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicinTouko Inao, Yuichi Iida, Tamami Moritani, et al.
Oncology Reports|July 6, 2007
Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancerShigenori Homma, Yoshihiro Komohara, Mamoru Harada, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivoMiki Tongu, Nanae Harashima, Hiroyuki Monma, et al.
Oncology Reports|January 5, 2006
Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patientsYi Wang, Mamoru Harada, Hirohisa Yano, et al.
Pageof 11